{
  "drug_id": "M045",
  "generic_name": "INFLIXIMAB-DYYB",
  "brand_names": [
    "INFLECTRA"
  ],
  "drug_class": "Tumor Necrosis Factor Blocker [EPC]",
  "indications": [],
  "dosage_protocol": null,
  "adverse_effects": [
    "Dyspnea",
    "Nausea",
    "Dizziness",
    "Hypertension",
    "Headache",
    "Fatigue",
    "Constipation",
    "Cough",
    "Bradycardia",
    "Rash"
  ],
  "adverse_effect_management": [],
  "contraindications": {
    "allergies": [
      "Hypersensitivity to this medication"
    ],
    "existing_diseases": [],
    "other_conditions": []
  },
  "drug_interactions": [
    {
      "drug_name_or_class": "NSAID",
      "effect": "May increase risk of bleeding"
    },
    {
      "drug_name_or_class": "warfarin",
      "effect": "Significantly increased bleeding risk"
    }
  ],
  "pregnancy_category": "Consult prescribing information",
  "special_populations": {
    "pregnancy": "Unknown",
    "breastfeeding": "Unknown",
    "pediatric": "Consult guidelines",
    "geriatric": "May need dose adjustment",
    "renal_impairment": "Monitor and adjust as needed",
    "hepatic_impairment": "Use with caution"
  }
}